With more than fifteen development candidates, Humabs has a broad and varied pipeline, internal and public health programs. These anti-infective immunotherapy candidates are being developed to treat a number of viral and bacterial diseases.
Humabs has a successful track record of advancing its leads through the early stages of development.
Humabs BioMed SA
Via dei Gaggini 3
T +41 91 825 63 80
F +41 91 825 64 92